Role of purines in brain development, from neuronal proliferation to synaptic refinement

The purinergic system includes P1 and P2 receptors, which are activated by ATP and its metabolites. They are expressed in adult neuronal and glial cells and are crucial in brain function, including neuromodulation and neuronal signaling. As P1 and P2 receptors are expressed throughout embryogenesis and development, purinergic signaling also has an important role in the development of the peripheral and central nervous system. In this review, we present the expression pattern and activity of purinergic receptors and of their signaling pathways during embryonic and postnatal development of the nervous system. In particular, we review the involvement of the purinergic signaling in all the crucial steps of brain development i.e. in neural stem cell proliferation, neuronal differentiation and migration as well as in astrogliogenesis and oligodendrogenesis. Then, we review data showing a crucial role of the ATP and adenosine signaling pathways in the formation of the peripheral neuromuscular junction and of central GABAergic and glutamatergic synapses. Finally, we examine the consequences of deregulation of the purinergic system during development and discuss the therapeutic potential of targeting it at adult stage in diseases with reactivation of the ATP and adenosine pathway. This article is part of the Special Issue on Purinergic Signaling: 50 years.

Automated summary

This article reviews the expression and activity of the purinergic system during embryonic and postnatal development of the nervous system, highlighting its crucial role in various steps of brain development. The involvement of purinergic signaling in neural stem cell proliferation, neuronal differentiation and migration, as well as astrogliogenesis and oligodendrogenesis, is discussed. Additionally, the importance of purinergic signaling in the formation of peripheral neuromuscular junctions and central GABAergic and glutamatergic synapses is examined, along with the potential therapeutic implications of targeting the purinergic system in diseases.